Australia's largest stock trading and investment forum Australia's #1 stock forum

WFL wellfully limited

0.00%

0.3¢

Revenue Questionnaire, page-9

First 9 Last

Share
Profile

Follow
rebel1

28,688 Posts.

853

02/05/18

21:00

Post #: 32841490
Share

Originally posted by hoofa ↑

It would not surprise me to see a consolidation of the share registry.

The current shares on offer of approx 2000,000,000 is a lot. It has ballooned out over a number of years with various allocations and all the other "stuff" that has gone on.

The company is now "perceived" as being an underperformer with a shareprice to match.

It needs to leave the penny dreadful shareprice arena and find itself a different space.

New Board, New Shareprice, New OBJ Company Focus, New Identity.

Sure P&G have helped them, "but" is the question.

P&G have a turnover of $65 billion. They take no prisoners.
OBJ is only important to P&G if the technology is successful and sells product with repeat sales.
The issue at the moment is that OBJ and the shareholders do not know what lies ahead. There is no 5/10 year contract in place with expected product revenues using the OBJ technology and hence projected royalities.
No one knows !!!! no one. The cosmetic industry seems to survive on change, marketing and 'the latest' fad. Historically that has always been the case. Marketing been a major element.
My original understanding as a substantial investor of the past, was that the "magnetic" technology was originally expressed as being a possible substitute for many chemicals used in various formulations. As this became clouded in my mind, I cash in my chips at a handsome profit.
It now seems to me that it is a new technology in a mechanical device for carrying cosmetic connoctions deeper into the skin. It may do this very well. But is that what the company is all about.
I have been looking for opportunities to become an investor once again, but I just am not seeing a clear path moving forward. There does not appear to be a clear identity for OBJ the company outside of the involvement with P&G.
OBJ does not have a product. No one really seems to understand what it is that they sell. If the "technology" is a low cost concept and does not require clinical trials/medical scrutiny and regulatory approvals - then what is its true value. Why hasnt the OBJ concept/technology been taken to the world markets as being adaptive to numerous products providing health and environmentals benefits. Instead it remains entrenched with P&G in a cosmetic wand.
Do you not want your company to make its own mark and announce a colloboration with any number of multi nationals with clout. Endorsing OBJ as the preferred way forward.

Instead it remains holding onto the apron strings of P&G - producing royalities that are peanuts when put into perspective. The longer it remains in this bubble, the longer its chance to grow and develop remains constrained imo.

It now needs to take calculated business planned risks and find its own way in the world.

The "mystery" is just not cutting it any more.

No offence to shareholders, it is just that I have followed this company for many years and think you deserve a better deal.

They are not delivering.

Expand

BHP have over 3 billion shares... its the same pie it doesnt matter how many pieces... when continuing revenue hits it will be a different company... until then we have to either wait or sell... its that simple

OBJ Price at posting: 2.6¢ Sentiment: Buy Disclosure: Held
10 Upvote

1 Great analysis

Reply

Top Stories

DRO

History repeats for DroneShield investors but carnage so far subdued

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

BDM

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

SYR

Syrah jumps +19% as graphite tariff threat spurs optimism down under

HotCopper Highlights: Trigg; Droneshield; Lumos & more

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.